AbbVie Updates U.S. Labels for VIEKIRA PAK® and TECHNIVIE™

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. SPY
2. ZION
3. MMM
4. GRMN
5. IT
6. STLD
7. META
8. AMZN
9. IRON
10. HBCP

Go back to AbbVie Updates U.S. Labels for VIEKIRA PAK® and TECHNIVIE™

AbbVie (ABBV) Updates Viekira Pak, Technivie Labels

October 23, 2015 6:22 AM EDT

AbbVie (NYSE: ABBV) announced the following on Friday:

In consultation with the U.S. Food and Drug Administration (FDA), the U.S. Product Inserts (USPI) for VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) and TECHNIVIE (ombitasvir, paritaprevir, and ritonavir tablets) have been updated from 'not recommended in Child Pugh B patients' to a contraindication in patients with Child-Pugh... More